Latest news
Nuvation Bio (NYSE: NUVB) posts $31.7M Q2 revenue and $62.8M loss - Stock TitanStock Titan · Thu, 06 Aug 2026 11:30:42 GMTNuvation Bio (NUVB) surges to $114.9M revenue and issues $250M notes - Stock TitanStock Titan · Thu, 06 Aug 2026 10:55:57 GMTNuvation Bio will present IBTROZI data across lung cancer subgroups - Stock TitanStock Titan · Tue, 04 Aug 2026 12:00:00 GMT